Airain Ltd’s Amphastar Pharmaceuticals AMPH Stock Holding History

Airain Ltd’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,700	Closed	-$160K	–	875
2015 Q1	$160K	Buy	+10,700	New	+$143K	0.01%	735

Other funds holding AMPH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Airain Ltd's AMPH Position: Q2 2015 in Review

Airain Ltd sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2015, closing a stake of 10,700 shares — an estimated $160K sold.

Airain Ltd first reported a position in AMPH in Q1 2015 and held it in 1 quarter. The position peaked at $160K in Q1 2015. 85 funds tracked by Wall St. Rank hold AMPH as of Q2 2015.

Airain Ltd reported no remaining Amphastar Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Airain Ltd sold 10,700 Amphastar Pharmaceuticals shares in Q2 2015, an estimated $160K.
Airain Ltd first reported a position in Amphastar Pharmaceuticals in Q1 2015 and held it in 1 quarter.
Airain Ltd's Amphastar Pharmaceuticals position peaked at $160K in Q1 2015.
85 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2015.

Based on Airain Ltd's 13F filing for Q2 2015, filed 5 Aug 2015.